Who is sponsoring NCT04787224?

NCT04787224 is sponsored by Cairo University.

What drugs are being tested in NCT04787224?

Interventions in NCT04787224: immediate implant with vestibular socket therapy.

What condition does NCT04787224 study?

NCT04787224 studies Implant Site Infection.

Is NCT04787224 still recruiting?

NCT04787224 is currently completed. Last updated 10 March 2021.

Last reviewed 2021-03-10 · How we verify

NCT04787224: VST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vestibular Socket Therapy (VST) in Infected and Non Infected Sockets

Completed Last updated 10 March 2021

What this trial tests

trial testing immediate implant with vestibular socket therapy in Implant Site Infection in 26 participants. Completed in 30 January 2021.

Timeline

15 January 2019

Primary endpoint
15 November 2020

30 January 2021

Quick facts

Lead sponsor	Cairo University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	15 January 2019
Primary completion	15 November 2020
Estimated completion	30 January 2021
Sites	2 locations across Egypt

Drugs / interventions tested

immediate implant with vestibular socket therapy

Conditions studied

Implant Site Infection — all drugs for Implant Site Infection →

Sponsor

Cairo University

Who can join

18 and older, any sex, with Implant Site Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Vestibular socket therapy with immediate implant placement is compared in infected and non-infected sockets regarding implant survival, bone thickness and soft tissue height .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Soft and hard tissue evaluation for vestibular socket therapy of immediately placed implants in infected and non-infected sockets: a 1-year prospective cohort study.
Elaskary A, Thabet A, Hussin M, Radi IA. · · 2024 · PMID 39375634 · DOI 10.1186/s12903-024-04905-3

Verify or expand the search:

Other recruiting trials for Implant Site Infection

Currently open trials in the same condition.

NCT06515886 — Characterizing the Inflammation Around Dental Implants: Bacterial Infection, Hypersensitivity or Both? · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04787224 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 10 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04787224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing